Picture of Carna Biosciences logo

4572 — Carna Biosciences News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Table: Garna Biosciences -2016 group results

Feb 10 (Reuters)-  
          Garna Biosciences Inc  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT    
                Dec 31, 2016    Dec 31, 2015   Dec 31, 2017     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales            811 mln          1.57           1.44                   
                 (-48.3 pct)    (+156.5 pct)    (+77.4 pct)               
  Operating     loss 423 mln       472 mln        39 mln                  
  Recurring     loss 440 mln       492 mln        35 mln                  
  Net 
  Net           loss 289 mln       456 mln         6 mln                  
  EPS          loss 31.64 yen     52.61 yen      0.71 yen                 
  EPS Diluted                     50.05 yen                               
  Ann Div            NIL             NIL            NIL                   
  -Q2 Div            NIL             NIL            NIL                   
  -Q4 Div            NIL             NIL            NIL                   
   
  NOTE - Garna Biosciences Inc. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Carna Biosciences

See all news